NeoGenomics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	727.33	660.57	591.64	509.73	484.33
Revenue Growth (YoY)	10.11%	11.65%	16.07%	5.24%	8.97%
Cost of Revenue	413.44	370.47	347.04	321.83	297.27
Gross Profit	313.89	290.1	244.6	187.9	187.06
Selling, General & Admin	346.46	330.04	313.94	310.68	283.94
Research & Development	37.08	31.16	27.31	30.33	21.87
Operating Expenses	383.54	361.2	341.25	341	305.81
Operating Income	-69.65	-71.1	-96.65	-153.11	-118.75
Interest Expense	-3.75	-6.62	-6.91	-7.58	-8.22
Interest & Investment Income	9.07	18.43	16.9	6.08	112.4
Other Non Operating Income (Expenses)	0.3	-0.38	0.64	-0.21	-0.5
EBT Excluding Unusual Items	-64.03	-59.66	-86.01	-154.83	-15.08
Merger & Restructuring Charges	-4.7	-6.66	-11.09	-4.52	-
Impairment of Goodwill	-3.5	-	-	-	-
Asset Writedown	-23.85	-	-	-	-
Legal Settlements	-11.28	-13.75	-	-	-
Other Unusual Items	-2.9	-0.6	-	-	-
Pretax Income	-110.27	-80.68	-97.1	-159.34	-15.08
Income Tax Expense	-2.24	-1.95	-9.13	-15.09	-6.73
Net Income	-108.03	-78.73	-87.97	-144.25	-8.35
Net Income to Common	-108.03	-78.73	-87.97	-144.25	-8.35
Shares Outstanding (Basic)	128	127	126	124	120
Shares Outstanding (Diluted)	128	127	126	124	120
Shares Change (YoY)	1.14%	0.92%	1.03%	3.55%	7.31%
EPS (Basic)	-0.84	-0.62	-0.70	-1.16	-0.07
EPS (Diluted)	-0.84	-0.62	-0.70	-1.16	-0.07
Free Cash Flow	-21.78	-34.04	-30.71	-96.88	-90.87
Free Cash Flow Per Share	-0.17	-0.27	-0.24	-0.78	-0.76
Gross Margin	43.16%	43.92%	41.34%	36.86%	38.62%
Operating Margin	-9.57%	-10.76%	-16.34%	-30.04%	-24.52%
Profit Margin	-14.85%	-11.92%	-14.87%	-28.30%	-1.72%
Free Cash Flow Margin	-2.99%	-5.15%	-5.19%	-19.01%	-18.76%
EBITDA	-1.82	1.45	-24.07	-83.68	-65.4
EBITDA Margin	-0.25%	0.22%	-4.07%	-16.42%	-13.50%
D&A For EBITDA	67.82	72.55	72.58	69.43	53.35
EBIT	-69.65	-71.1	-96.65	-153.11	-118.75
EBIT Margin	-9.57%	-10.76%	-16.34%	-30.04%	-24.52%
Revenue as Reported	-	-	-	-	484.33

Updated Feb 17, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q